Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How has the celiac disease treatment market size changed in recent years, and what is the outlook ahead?
The celiac disease treatment market size has grown strongly in recent years. It will grow from $0.61 billion in 2024 to $0.67 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rise in prevalence of celiac disease, increase in awareness and diagnosis rates, growth in demand for non-dietary treatment options, strong pipeline of innovative therapies, supportive regulatory initiatives, and increase in investment from pharmaceutical companies.
The celiac disease treatment market size is expected to see strong growth in the next few years. It will grow to $0.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to rising global prevalence of celiac disease, increasing awareness and diagnosis rates, ongoing clinical trials for novel treatments, growing demand for gluten-free alternatives, supportive regulatory initiatives for orphan diseases, and rising healthcare expenditure. Major trends in the forecast period include adoption of novel non-dietary therapies, advancements in enzyme supplements, personalized medicine approaches, development of peptide-based immunotherapies, improved diagnostic tools, and advancements in clinical trials.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp
What are the top economic and technological drivers pushing celiac disease treatment market growth?
The rise in the prevalence of diabetes is expected to propel the growth of the celiac disease treatment market going forward. Diabetes is a chronic medical condition where the body is unable to regulate blood sugar or glucose levels properly. The increasing prevalence of diabetes is due to shared dietary management needs, as both diabetes and celiac disease require careful control of food intake to manage blood sugar levels and prevent complications. Celiac disease treatment aids diabetes by promoting a gluten-free diet, which can help improve overall digestive health and nutrient absorption. It supports better blood sugar control and reduces complications in individuals managing both conditions. For instance, in June 2024, according to the National Health Service, a UK-based government department, around 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the rise in the prevalence of diabetes is driving the growth of the celiac disease treatment market.
How is the celiac disease treatment market segmented by product, application, and end-user?
The celiac disease treatment market covered in this report is segmented –
1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments
2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue
3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy
4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels
Subsegments:
1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins
2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations
3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents
4) By Other Treatments: Probiotics, Immunotherapy, Stem Cell Therapy, Experimental Therapies
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report
What evolving trends are creating new opportunities in the celiac disease treatment market?
Major companies operating in the celiac disease treatment market are focusing on developing oral therapies, such as small molecule therapies, to provide targeted relief by blocking immune responses to gluten, improving patient adherence, and offering alternatives to strict gluten-free diets. Small molecule therapies are tiny drugs that enter cells easily to target and treat disease-causing proteins or enzymes. For instance, in February 2025, Immunic Inc., a US-based biotechnology company, launched IMU-856. IMU-856 is a small molecule that increases endogenous glucagon-like peptide-1 (GLP-1) levels, which helps improve intestinal barrier function in celiac disease patients. It also enhance nutrient absorption and alleviate symptoms without suppressing immune activity.
Which leading companies are dominating the celiac disease treatment market landscape?
Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX
Which geographic areas are expected to offer the highest growth opportunities in theceliac disease treatment market?
North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Celiac Disease Treatment Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp
Need Customized Data On Celiac Disease Treatment Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
